FUNI Stock Overview

Engages in the research, development, and commercialization of a bioreactor in the United States. More details

FUNI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue ($0)

Does not have a meaningful market cap ($4M)

Negative shareholders equity

Has less than 1 year of cash runway

+ 2 more risks

Hypha Labs, Inc. Competitors

Aterian

NasdaqCM:ATER

US$14.3m

Fenbo Holdings

NasdaqCM:FEBO

US$13.5m

iRobot

NasdaqGS:IRBT

US$75.1m

Viomi Technology

NasdaqGS:VIOT

US$89.4m

Price History & Performance

Summary of share price highs, lows and changes for Hypha Labs
Historical stock prices
Current Share Price	US$0.029
52 Week High	US$0.06
52 Week Low	US$0.0073
Beta	0.55
1 Month Change	0.17%
3 Month Change	13.17%
1 Year Change	-7.73%
3 Year Change	81.25%
5 Year Change	-44.23%
Change since IPO	-99.71%

Recent updates

Shareholder Returns

	FUNI	US Consumer Durables	US Market
7D	-3.3%	5.4%	7.1%
1Y	-7.7%	-10.4%	7.7%

Return vs Industry: FUNI exceeded the US Consumer Durables industry which returned -10.5% over the past year.

Return vs Market: FUNI underperformed the US Market which returned 7.5% over the past year.

Price Volatility

Is FUNI's price volatile compared to industry and market?
FUNI volatility
FUNI Average Weekly Movement	17.7%
Consumer Durables Industry Average Movement	7.8%
Market Average Movement	7.8%
10% most volatile stocks in US Market	16.4%
10% least volatile stocks in US Market	4.1%

Stable Share Price: FUNI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: FUNI's weekly volatility has decreased from 30% to 18% over the past year, but is still higher than 75% of US stocks.

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

About the Company

Founded	Employees	CEO	Website
2010	17	A. Douglass	hyphalabs.com

Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. The company was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Hypha Labs, Inc. Fundamentals Summary

How do Hypha Labs's earnings and revenue compare to its market cap?
FUNI fundamental statistics
Market cap	US$3.97m
Earnings (TTM)	-US$2.57m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-1.5x

P/E Ratio

Is FUNI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FUNI income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$2.57m
Earnings	-US$2.57m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.019
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	-89.2%

How did FUNI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/28 09:19
End of Day Share Price	2025/04/28 00:00
Earnings	2024/12/31
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hypha Labs, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.